The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells

Molecular and Cellular Biochemistry

Volumn 378, Issue 1-2, 2013, Pages 1-7

  Yan, Yan ^a   Liu, Huidi ^a   Wen, Haixia ^a   Jiang, Xueli ^a   Cao, Xuefeng ^a   Zhang, Guangmei ^b   Liu, Guoyi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

GPER; Invasion; Migration; MMP 9; Ovarian cancer

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED ESTROGEN RECEPTOR; GELATINASE B; PERTUSSIS TOXIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL ASSAY; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY; CELL MOTION; FEMALE; GENE SILENCING; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

CELL LINE, TUMOR; CELL MOVEMENT; ENZYME INDUCTION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84875933432     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1579-9     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. C.A. Cancer J Clin 56:106-130
2. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351: 2519-2529
3. Hunn J, Rodriguez GC (2012) Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 55:3-23
4. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, Lazennec G (2004) Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 64:5861-5869
5. Markman M, Iseminger KA, Hatch KD, Creasman WT, Barnes W, Dubeshter B (1996) Tamoxifen in platinum-refractory ovarian cancer: a gynecologic oncology group ancillary report. Gynecol Oncol 62:4-6
6. Havrilesky LJ, McMahon CP, Lobenhofer EK, Whitaker R, Marks J.R., Berchuck A (2001) Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones. J Soc Gynecol Investig 8:104-113
7. Wang D, Hu L, Zhang G, Zhang L, Chen C (2010) G proteincoupled receptor 30 in tumor development. Endocrine 38:29-37
8. Prossnitz ER, Barton M (2011) The G-protein-coupled estrogen receptorGPERin health and disease.Nat Rev Endocrinol 7:715-726
9. Ruan SQ, Wang ZH, Wang SW, Fu ZX, Xu KL, Li DB, Zhang SZ (2012) Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-M.A.PK/ERK pathway. Biochem Biophys Res Commun 420:385-390
10. Du GQ, Zhou L, Chen XY, Wan XP, He YY (2012) The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem Biophys Res Commun 420:343-349
11. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER (2009) GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465-471
12. Kolkova Z, Casslén V, Henic E, Ahmadi S, Ehinger A, Jirström K, Casslén B (2012) The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer. J Ovarian Res 5:9
13. Liu HD, Yan Y, Cao XF, Tan PZ, Wen HX, Lv CM, Li XM, Liu GY (2010) The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9. Sheng Li Xue Bao 62:524-528
14. Sporn MB (1996) The war on cancer. Lancet 347:1377-1381
15. Auersperg N, Ota T, Mitchell GW (2002) Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int J Gynecol Cancer 12:691-703
16. Song J, Fadiel A, Edusa V, Chen Z, So J, Sakamoto H, Fishman DA, Naftolin F (2005) Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett 220:57-65
17. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D (2009) Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28:523-532
18. He YY, Du GQ, Cai B, Yan Q, Zhou L, Chen XY, Lu W, Yang YX, Wan XP (2012) Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2. J Cancer Res Clin Oncol 138:775-783
19. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E (2006) Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359-6366
20. Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER (2007) GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196:386. e1-386.e11
21. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-1866
22. Lau MT, So WK, Leung PC (2012) Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. Cancer Lett 320:198-204
23. Henic E, Noskova V, Høyer-Hansen G, Hansson S, Casslén B (2009) Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int J Gynecol Cancer 19:214-222
24. Peng TL, Chen J, Mao W, Song X, Chen MH (2009) Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 10:27
25. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ (2002) Contributions of stromal metalloproteinase- 9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134-1142